Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model

Krzysztof Szymanowski, Karolina Chmaj-Wierzchowska, Andrey Yantczenko, Joanna Niepsuj-Biniaś, Ewa Florek, Tomasz Opala, Marek Murawski
European journal of obstetrics, gynecology, and reproductive biology · 2008 · vol. 142(2) , pp. 145–148 · doi:10.1016/j.ejogrb.2008.09.017 · PMID:19059697 · W2073687468
article OA: closed CC0 ⤵ 10 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study investigated the efficacy of the novel xenogenic immunomodulator RESAN for both preventing and treating endometriosis in an animal model.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Cancer Vaccines Endometriosis Immunologic Factors Animals Antigens, Heterophile Antigens, Heterophile Cancer Vaccines Disease Models, Animal Endometriosis Endometriosis Female Immunologic Factors Rats Rats, Wistar Tissue Adhesions Tissue Adhesions

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (10)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:18.065553+00:00
License: CC0 · commercial use OK